More about

Endocrine Disruptor

Clinical Guidance
Type 2 Diabetes
Pharmacologic Intervention

Glucoregulatory Hormones and GLP-1/GIP Receptor Agonists

Steven V. Edelman, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

News
October 31, 2022
2 min read
Save

Prenatal phthalate exposure reduces lung function in childhood

Prenatal phthalate exposure reduces lung function in childhood

Gestational exposure to phthalates was linked to lower FVC and FEV1 during childhood, particularly early childhood, with four phthalates demonstrating a significant association, concluded recent results.

News
February 16, 2020
1 min read
Save

Effects of endocrine-disrupting chemicals extend to obesity, osteoporosis, IQ and beyond

Effects of endocrine-disrupting chemicals extend to obesity, osteoporosis, IQ and beyond

Although causality is difficult to prove definitively, mounting evidence suggests adverse health consequences of endocrine-disrupting among humans. Recent research links these ubiquitous compounds to pediatric obesity, diabetes, osteoporosis and more.

News
August 02, 2019
2 min read
Save

Certain medications linked to increased breast cancer risk

Women with high cumulative exposure to dibutyl phthalate through medications appeared to be at increased risk for ER-positive breast cancer, according to results of a retrospective study published in Journal of Clinical Oncology.